[1]
A. Pagliaro, S. Rossi, A. Santoro, and L. Toschi, “Psychiatric symptoms in patients with metastatic ALK-positive NSCLC treated with third-generation ALK-inhibitors: a brief review and case series”, JMS, vol. 93, no. 3, p. e986, Sep. 2024, doi: 10.20883/medical.e986.